Sector: Health Care
Director information for ALTIMMUNE INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Catherine Sohn, Pharm D. | Director | 72 | ["Doctor of Pharmacy degree from the University of California, San Francisco","Corporate Directors Certificate from Harvard Business School","Certificate of Professional Development from Wharton","Certificate from UC Berkeley Law for environmental, social and corporate governance","Stanford Directors College attendee","Certified Licensing Professional Emeritus","Former senior vice president at GlaxoSmithKline","Experience in board advising and strategy for life science companies","Entrepreneurial experience in pharmaceutical company"] | ["Compensation","Nom/Gov","Audit","R&D","Transaction"] | 2026 |
| Diane Jorkasky, M.D. | Member of the Board of Directors | 74 | ["Executive Vice President, Chief Medical Officer and Head of Development at Complexa Inc.","Extensive vice president responsibilities in translational sciences and clinical development at SmithKline Beecham and Pfizer","DR. Jorkasky received her M.D. from the University of Pennsylvania School of Medicine","Board certified in internal medicine, nephrology and clinical pharmacology"] | [] | 2026 |
| Jerome Durso | Chairman of the Board; President and Chief Executive Officer | 58 | ["Over 30 years of experience in building and leading commercial and business operations in life sciences organizations","Public company executive with a long-term track record of success working at the intersection of strategy and operations","Experience as Chief Executive Officer and member of the Board of Directors of Intercept Pharmaceuticals","Former Chief Operating Officer of Intercept Pharmaceuticals","Former Senior Vice President, Chief Commercial Officer of Sanofi’s Global Diabetes Division","BBA in Marketing from the University of Notre Dame"] | [] | 2026 |
| John M. Gill | Director | 74 | ["Served as President and Chief Executive Officer of PharmAthene from March 2015 until May 2017","Co-founder and Director of TetraLogic Pharmaceuticals Corporation from 2003 to 2013","Experience at 3 Dimensional Pharmaceuticals and SmithKline Beecham","Served in the United States Marine Corps","B.A. in Accounting and Economics from Rutgers University"] | [] | 2026 |
| Klaus O. Schafer, M.D., MPH | Member of the Board of Directors | 76 | ["Over 35 years of healthcare leadership experience","Former Acting Deputy Assistant to the Secretary of Defense for chemical and biological defense","Managed large integrated health care delivery systems as U.S. Air Force Assistant Surgeon General","CEO and co-founder of TessArae LLC","Chief Medical Officer and client executive for health at CACI International","Independent consultant since 2002 for biotech and health-related company advisory boards","CERT certified in Cybersecurity Oversight from Carnegie Mellon University Software Engineering Institute"] | [] | 2026 |
| Mitchel Sayare, Ph.D. | Chairman of the Board | 78 | ["Chairman of the Board of ImmunoGen, Inc. since 1989","Chief Executive Officer of ImmunoGen from 1986 to December 31, 2009","Leadership experience in the biotechnology industry","Substantial governance experience as a board member and executive officer","Ph.D. in biochemistry"] | [] | 2026 |
| Philip L. Hodges | Member of the Board of Directors | 57 | ["Managing Partner of Redmont & Company","Focus on investment and advisory services for emerging growth businesses","Experience as a life science investor","Strategic advisory work with emerging healthcare and technology companies"] | [] | 2026 |
| Teri Lawver | Member of the Board of Directors | 59 | ["Chief Commercial Officer at Celldex","Principal and Owner of Thera Lifescience Advisors LLC","Executive Vice President and Chief Commercial Officer at Dexcom","Held leadership roles at Johnson & Johnson Corporation","Consultant and Associate Principal at McKinsey & Company"] | [] | 2026 |
| Wayne Pisano | Director | 71 | ["President and Chief Executive Officer of VaxInnate Corporation","Depth of experience across global vaccine development","Experience in public immunization policy and commercial operations","Experience in strategic pipeline advancement","Experience in board governance"] | [] | 2026 |
